SCHEMBL32690804

SCHEMBL32690804

COC(=O)/C=C/c1ccc2[nH]c(-c3ccccc3C)c(O)c(=O)c2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCNB2 O95067 1/20 0.44
▸ CDK1 P06493 1/20 0.44
▸ CCNB1 P14635 1/20 0.44
▸ GSK3B P49841 1/20 0.44
▸ CDK5 Q00535 1/20 0.44
▸ CDK5R1 Q15078 1/20 0.44
▸ CCNB3 Q8WWL7 1/20 0.44
▸ TTR P02766 1/20 0.43
▸ APP P05067 1/20 0.43
▸ PTPN1 P18031 1/20 0.42
▸ EPHX2 P34913 1/20 0.41
▸ NPC1 O15118 2/20 0.41
▸ RAB9A P51151 2/20 0.41
▸ IP6K1 Q92551 1/20 0.41
▸ IP6K3 Q96PC2 1/20 0.41
▸ IP6K2 Q9UHH9 1/20 0.41
▸ CASP3 P42574 1/20 0.41
▸ SENP8 Q96LD8 1/20 0.41
▸ SENP7 Q9BQF6 1/20 0.41
▸ SENP6 Q9GZR1 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32690795 0.89 CCNB2 (0.45) CCNB2CDK1CCNB1GSK3BCDK5
SCHEMBL32690687 0.89 EPHX2 (0.48) CCNB2CDK1CCNB1GSK3BCDK5
SCHEMBL32690705 0.88 HDAC1 (0.48) APPHDAC3HDAC1HDAC6
SCHEMBL32690662 0.86 CCNB2 (0.49) CCNB2CDK1CCNB1GSK3BCDK5
SCHEMBL32690654 0.79 HDAC1 (0.47) MAPTHDAC3HDAC1HDAC6
SCHEMBL32690720 0.78 CCNB2 (0.45) CCNB2CDK1CCNB1GSK3BCDK5
SCHEMBL30440640 0.77 KIF11 (0.55) TTRAPPPTPN1EPHX2RAB9A
SCHEMBL12408499 0.77 KIF11 (0.55) TTRAPPPTPN1EPHX2RAB9A
SCHEMBL1071505 0.77 KIF11 (0.55) TTRAPPPTPN1EPHX2RAB9A
SCHEMBL32690820 0.75 HDAC1 (0.44) HDAC3HDAC1HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260085046-A1 Dual Function Compounds For NADPH Oxidase Inhibition And Histone Deacetylase Inhibition TAIWANJ PHARMACEUTICALS CO LTD (TW) 2026-03-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260085046-A1 Dual Function Compounds For NADPH Oxidase Inhibition And Histone Deacetylase Inhibition NOX1, NOX4, CYBB CCNB2 3869/4885CDK1 2371/4885CCNB1 2565/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback